{
  "id": [
    "25373629"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "25373629"
  ],
  "pmcid": [
    "PMC4246125"
  ],
  "doi": [
    "10.1007/s40263-014-0212-0"
  ],
  "title": [
    "Authors' reply to Whitlock: Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence."
  ],
  "authorString": [
    "Ignatowski TA, Spengler RN, Tobinick E."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Ignatowski TA"
          ],
          "firstName": [
            "Tracey A"
          ],
          "lastName": [
            "Ignatowski"
          ],
          "initials": [
            "TA"
          ],
          "affiliation": [
            "Department of Pathology and Anatomical Sciences and Program for Neuroscience, School of Medicine and Biomedical Sciences, The State University of New York, Buffalo, NY, USA."
          ]
        },
        {
          "fullName": [
            "Spengler RN"
          ],
          "firstName": [
            "Robert N"
          ],
          "lastName": [
            "Spengler"
          ],
          "initials": [
            "RN"
          ]
        },
        {
          "fullName": [
            "Tobinick E"
          ],
          "firstName": [
            "Edward"
          ],
          "lastName": [
            "Tobinick"
          ],
          "initials": [
            "E"
          ]
        }
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "12"
      ],
      "volume": [
        "28"
      ],
      "journalIssueId": [
        "2223244"
      ],
      "dateOfPublication": [
        "2014 Dec"
      ],
      "monthOfPublication": [
        "12"
      ],
      "yearOfPublication": [
        "2014"
      ],
      "printPublicationDate": [
        "2014-12-01"
      ],
      "journal": [
        {
          "title": [
            "CNS drugs"
          ],
          "ISOAbbreviation": [
            "CNS Drugs"
          ],
          "medlineAbbreviation": [
            "CNS Drugs"
          ],
          "NLMid": [
            "9431220"
          ],
          "ISSN": [
            "1172-7047"
          ],
          "ESSN": [
            "1179-1934"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2014"
  ],
  "pageInfo": [
    "1207-1213"
  ],
  "affiliation": [
    "Department of Pathology and Anatomical Sciences and Program for Neuroscience, School of Medicine and Biomedical Sciences, The State University of New York, Buffalo, NY, USA."
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "Letter",
        "Comment"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Animals"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Immunoglobulin G"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AD"
                  ],
                  "qualifierName": [
                    "administration & dosage"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Receptors, Tumor Necrosis Factor"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AD"
                  ],
                  "qualifierName": [
                    "administration & dosage"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Neuroprotective Agents"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AD"
                  ],
                  "qualifierName": [
                    "administration & dosage"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Cognition Disorders"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "ET"
                  ],
                  "qualifierName": [
                    "etiology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Stroke"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "CO"
                  ],
                  "qualifierName": [
                    "complications"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Immunoglobulin G"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Receptors, Tumor Necrosis Factor"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Neuroprotective Agents"
          ],
          "registryNumber": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC4246125?pdf=render"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC4246125"
          ]
        },
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1007/s40263-014-0212-0"
          ]
        }
      ]
    }
  ],
  "commentCorrectionList": [
    {
      "commentCorrection": [
        {
          "id": [
            "25373628"
          ],
          "source": [
            "MED"
          ],
          "reference": [
            "CNS Drugs. 2014 Dec;28(12):1205-6"
          ],
          "type": [
            "Comment on"
          ],
          "orderIn": [
            "1"
          ]
        },
        {
          "id": [
            "24861337"
          ],
          "source": [
            "MED"
          ],
          "reference": [
            "CNS Drugs. 2014 Aug;28(8):679-97"
          ],
          "type": [
            "Comment on"
          ],
          "orderIn": [
            "2"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "4"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2015-05-21"
  ],
  "dateOfCreation": [
    "2014-11-28"
  ],
  "dateOfRevision": [
    "2017-11-13"
  ],
  "firstPublicationDate": [
    "2014-12-01"
  ]
}